Author

N. Y. Gizaw

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

C. Haglund· 1 shared E. Gucciardo· 1 shared K. Alitalo· 1 shared K. Lehti· 1 shared M. Kinnunen· 1 shared M. Sampo· 1 shared M. Varjosalo· 1 shared P. Kallio· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. Haglund

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintApr 19, 2020

PROX1 transcription factor is a master regulator of myogenic and oncogenic features of rhabdomyosarcoma

N. Y. Gizaw, P. Kallio, T. Punger…·R. Kivela

This study identifies PROX1 as a master regulator of myogenic and oncogenic features in rhabdomyosarcoma, showing its role in stemness, tumor growth, and therapeutic potential through HDAC interactions.

DOI 10.1101/2020.04.19.045989

humanbulk RNA-seq

𝕏 PostBluesky